Centre Hospitalier Régional Universitaire Hôpital Saint Eloi

Montpellier 34295

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Metastatic Pancreatic Adenocarcinoma

Studies at this site

• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early
• A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP) — Completed